50.79 USD
-0.99
1.91%
At close Updated Nov 18, 1:47 PM EST
1 day
-1.91%
5 days
-2.25%
1 month
2.13%
3 months
1.91%
6 months
-2.85%
Year to date
5.4%
1 year
4.7%
5 years
0.57%
10 years
14.5%
 

About: Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Employees: 82,878

0
Funds holding %
of 7,380 funds
0
Analysts bullish %
of 1 analysts
0
Positive news %
of 22 articles
Price charts implemented using Lightweight Charts™